Back to search
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how th…
The goal of this observational study is to learn about the natural history and multi-organ involvement of Laminin-Alpha-2-Related Dystrophy (LAMA2-RD) in pediat…
The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of LAMA2-related dystrophies (LAMA2…
This retrospective chart review study of 75-120 LAMA2-CMD patients will expand the investigators understanding of the natural history of this disease. Current a…
Laminin alpha-2 (LAMA2)-related muscular dystrophy (LAMA2-MD, Merosin Deficient CMD) is a form of congenital muscular dystrophy (CMD). A person with LAMA2-MD wi…